Kristin Kaasen Jørgensen

7PUBLICATIONS
23CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityAllergyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
Vaccination of immunosuppressed patients.

|Nov 21, 2023
[Primary sclerosing cholangitis].

Holmfridur Helgadottir, Trine Folseraas, Gunter Kemmerich

|Feb 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken

|May 04, 2022
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.

Silje W Syversen, Ingrid Jyssum, Anne T Tveter

|Sep 23, 2020
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.

Kristin K Jørgensen, Guro L Goll, Joe Sexton

Pageof 2